Table 2 Antimicrobila resistance genes of KP617 and the reference strains

Aminoglycosides

aacA4

100

555/555

Aminoglycoside resistance

KM278199

P3_115183..115737

aac(3)-IIa

99.77

861/861

X51534

P2_41114..41974

aac(3)-IId

99.88

861/861

EU022314

P3_64003..64863

aac(6′)-Ib

100

606/606

M21682

P3_2456..3061

P2_82742..83347

aadA1

100

789/789

JQ480156

P3_3131..3919

99.75

792/798

JQ414041

P3_44412..45203

aadA2

100

792/792

JQ364967

P1_261911..262702

P1_271654..272445

P1_53050..53841

100

780/780

X68227

C_2297697..2298476

aph(3′)-VIa

98.46

780/780

X07753

P1_4558..5337

P1_4558..5337

armA

100

774/774

AY220558

P1_267391..268164

P1_277134..277907

rmtC

100

AB194779

P3_120100..120945

strA

99.88

804/804

AF321551

P3_29207..30010

100

P2_53242..54045

strB

99.88

837/837

M96392

P3_30010..30846

100

P2_52406..53242

aac(6′)Ib-cr

100

600/600

Fluoroquinolone and aminoglycoside resistance

DQ303918

C_612688..613287

C_1122863..1123462

P1_136163..136762

P2_38111..38710

Beta-lactams

blaOXA-1

100

831/831

Beta-lactam resistance

J02967

C_613418..614248

C_1121902..1122732

P1_136893..137723

P2_38841..39671

blaOXA-9

100

840/840

JF703130

P3_3964..4803

blaOXA-232

100

798/798

JX423831

P2_3878..4675

P4_3878..4675

blaNDM-1

100

813/813

FN396876

P1_7770..8582

P1_7770..8582

P3_122191..123003

blaNDM-5

100

813/813

JN104597

P2_10716..11528

blaCTX-M-15

100

876/876

DQ302097

C_5407907..5408782

P3_68389..69264

P2_47128..48003

P1_47694..48569

blaTEM-1A

100

861/861

HM749966

P3_5503..6363

blaTEM-1B

100

861/861

JF910132

P2_50825..51685

595/861

P1_49351..49945

blaSHV-11

100

861/861

GQ407109

P3_57446..58306

C_2612965..2613825

99.88

P2_36311..37171

blaSHV-28

100

861/861

HM751101

C_1087615..1088475

99.88

C_1078475..1079335

C_656815..657675

blaCMY-6

100

1146/1146

AJ011293

P3_72203..73348

Fluoroquinolones

aac(6′)Ib-cr

100

600/600

Fluoroquinolone and aminoglycoside resistance

DQ303918

C_612688..613287

C_1122863..1123462

P1_136163..136762

P2_38111..38710

99.42

519/519

EF636461

P3_2543..3061

P2_82742..83260

99.61

P3_115219..115737

QnrB1

99.85

682/681

Quinolone resistance

EF682133

P1_130519..131200

P1_130247..130928

QnrB58

98.68

681/681

JX259319

P2_26062..26742

oqxA

100

1176/1176

EU370913

C_4169699..4170874

99.23

C_4847144..4848319

C_4793024..4794199

C_4849531..4850706

oqxB

98.83

3153/3153

EU370913

C_4843968..4847120

C_4789848..4793000

C_4170898..4174050

98.79

C_4846355..4849507

Fosfomycin

fosA

97.38

420/420

Fosfomycin resistance

NZ_AFBO01000747

C_2957629..2958048

C_2903507..2903926

C_2946180..2946599

97.14

C_667959..668378

MLS—macrolide, lincosamide and streptogramin B

ere(A)

95.11

1227/1227

Macrolide resistance

AF099140

P3_45289..46515

mph(A)

100

906/906

D16251

P1_16503..17408

mph(E)

99.89

885/885

EU294228

P1_271994..272878

P1_281737..282621

msr(E)

100

1476/1476

Macrolide, Lincosamide and Streptogramin B resistance

EU294228

P1_270463..271938

P1_280206..281681

Phenicol

catB3

100

442/633

Phenicol resistance

AJ009818

P1_137861..138302

P2_39809..40250

C_614386..614827

C_1121323..1121764

cmlA1

99.13

AB212941

P3_42931..44190

Rifampicin

ARR-2

100

453/453

Rifampicin resistance

HQ141279

P3_46791..47243

ARR-3

CP002151

C_2298894..2299820

Sulphonamides

sul1

100

927/927

Sulphonamide resistance

CP002151

P1_263120..264046

P1_272863..273789

P3_116160..117086

sul1

100

837/837

JN581942

P3_41559..42395

sul2

100

816/816

GQ421466

P3_28331..29146

Tetracyclines

tet(A)

100

1200/1200

Tetracycline resistance

AJ517790

P1_19168..20367

Trimethoprim

dfrA1

100

474/474

Trimethoprim resistance

X00926

C_3627607..3628080

C_3573485..3573958

dfrA12

100

498/498

AB571791

P1_261006..261503

P1_270749..271246

P1_52145..52642

dfrA14

99.59

483/483

DQ388123

P1_144525..145007

P2_8272..8754